CVE-2023-27875

IBM Aspera Faspex improper access controls

Description

IBM Aspera Faspex 5.0.4 could allow a user to change other user's credentials due to improper access controls. IBM X-Force ID: 249847.

Category

7.5
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.04%
Vendor Advisory ibm.com Vendor Advisory ibmcloud.com
Affected: IBM Aspera Faspex
Published at:
Updated at:

References

Link Tags
https://www.ibm.com/support/pages/node/6963662 patch vendor advisory
https://exchange.xforce.ibmcloud.com/vulnerabilities/249847 vdb entry vendor advisory

Frequently Asked Questions

What is the severity of CVE-2023-27875?
CVE-2023-27875 has been scored as a high severity vulnerability.
How to fix CVE-2023-27875?
To fix CVE-2023-27875, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-27875 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-27875 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-27875?
CVE-2023-27875 affects IBM Aspera Faspex.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.